See inside every stock. Pro
S&P 5007,720▼ 0.30%Nasdaq26,185▼ 1.38%Dow Jones52,343▼ 0.25%Nasdaq 10029,403▼ 1.38%VIX17.20▲ 1.71%US Dollar101.93▼ 0.26%Gold spot4,054▼ 0.21%WTI103.72▲ 1.69%
← 0LEE page
XStocksXray
Market X-Ray report · 28 October 2026

Teradata Corp. (0LEE)

London Stock Exchange · UK · prices in USD · close of 28 Oct 2026

Key indicators

Last closeUSD 34.08
52-week range20.60 – 41.79
Return, 1 month / 3 months+20.1% / +14.1%
Return, 1 year / 3 years+58.3% / −19.4%
TrendUptrend
RSI (14)73
Volatility (1 year)62.5%
Worst drawdown (1 year)-33.1%
Average daily value traded0.05M USD
Dividend yield–

Market X-Ray price-based

53/ 100 · High confidence · ahead of 50% of stocks on this exchange
Trend62
Momentum84
Stability (higher is calmer)30
Liquidity24
Income–

Five-year price chart navy: price · brown: 200-day average

16.1527.5138.8750.2361.592021-102023-112024-112025-112026-10

About the company

Teradata Corp. supplies data warehousing, analytics and data management software and related services to large organisations. Its main offering is the Teradata Vantage platform, which lets companies store, integrate and analyse large volumes of data. Customers include businesses in industries such as retail, financial services, manufacturing and telecommunications, who use the technology for reporting, business intelligence and operational analytics. The company is based in the United States.

On this site Teradata Corp. appears as a stock on the London Stock Exchange (UK), code 0LEE, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Teradata Corp. (0LEE) trades on the London Stock Exchange in UK. It last closed at USD 34.08 on 28 October 2026.

Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,887 of 3,789 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 58.3% and over the last three months it rose 14.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Teradata Corp. (0LEE)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend62 · FairMixed trend against its averages.
Above 200-day average14.3%
From 52-week high-8.6%
Momentum84 · StrongRising faster than most stocks on this exchange.
3-month return14.1%
6-month return32.4%
12-month return, skipping the last month31.8%
Stability (higher is calmer)30 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)62.5%
Worst drawdown, 1 year (smaller is calmer)-33.1%
Liquidity24 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.05M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+11.6%
1 month+20.1%
3 months+14.1%
6 months+32.4%
1 year+58.3%
3 years−19.4%
5 years−39.4%

Signals

50-day / 200-day average28.72 / 29.81
Golden / death cross (60 days)Death, 25 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.27

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 30 Oct 2026